The Centers for Medicare & Medicaid Services today issued a proposed rule that would revise regulations setting forth the appeals process that Medicare beneficiaries, providers and suppliers must follow in order to appeal adverse determinations regarding claims for benefits under Medicare Parts A and B and prescription drug coverage under Part D. The agency said the changes are intended to streamline and clarify the appeals process and reduce administrative burdens.
Special Bulletin on CMS’s Nov. 26 proposed rule aimed at lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.
Download the letter (PDF) below Re: CMS—3346—P, Medicare
On Sept. 20, the Centers for Medicare…
The Centers for Medicare…
Special Bulletin: CMS Releases Advanced Notice of Proposed Rulemaking on Medicare Part B Prescription Drug Payment Model
On October 25, the Centers for Medicare…